<DOC>
	<DOCNO>NCT03070561</DOCNO>
	<brief_summary>Open label , cross-over , local pharmacokinetics study sublingual film peanut extract healthy adult child</brief_summary>
	<brief_title>Evaluating Peanut Immunotherapy Dissolving Film Healthy Subjects</brief_title>
	<detailed_description>In study , 15 non-peanut allergic child adult enrol . At three visit , least day apart , study product ( dissolve film ) contain approximately 60 mcg major peanut allergen ( Ara h 2 ) , equivalent approximately 1000 mcg peanut protein , place one three area : sublingual space , affixed buccal mucosa , vestibular space . Concentrations Ara h2 saliva collect several location several time point mouth analyzed ELISA .</detailed_description>
	<mesh_term>Peanut Hypersensitivity</mesh_term>
	<criteria>Age â‰¥ 3 year &lt; 30 year . Able give inform consent . English speaking language impairment Regularly consume meal size portion ( approximately 5 gram ) peanut least twice per month precede 6 month History reaction peanut Major active medical problem oral cavity use medication might change rate salivation</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>